Brainsway Ltd (BRIN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Brainsway Ltd (BRIN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6610
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It offers deep TMS that used for treatment of depressive episodes in adult patients suffering from depressive disorder. Brainsway conducts various clinical research programs. The company also operates online portals for patients, physicians and researchers, among others. It partners with various institutions and researchers in clinical trials covering various neuropsychiatric, neuroscience applications, and others. The company operates in Israel. Brainsway is headquartered in Jerusalem, Israel.

Brainsway Ltd (BRIN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Brainsway Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Brainsway Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Brainsway Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Brainsway Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Brainsway Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Brainsway Ltd, Medical Equipment, Deal Details 10
Private Equity 10
Brainsway Raises USD8.5 Million in Financing 10
Partnerships 11
Medison Pharma Enters into Marketing and Distribution Agreement with Brainsway 11
Brainsway Enters into Distribution Agreement with Moksha8 Pharma 12
Brainsway Enters Into Co-Marketing Agreement For Deep TMS System 13
Equity Offering 14
Brainsway Completes Private Placement Of Shares For US$11.8 Million 14
Brainsway Completes Public Offering Of Shares For US$6.7 Million 15
Brainsway Raises USD1 Million in Private Placement of Shares 16
Brainsway Ltd – Key Competitors 17
Brainsway Ltd – Key Employees 18
Brainsway Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Aug 27, 2018: Brainsway announces financial results for second quarter of 2018 20
May 29, 2018: Brainsway Reports Record Financial Results for First Quarter of 2018 and Provides Corporate Update 22
Mar 19, 2018: Brainsway Announces Fourth Quarter and Full-Year 2017 Financial Results 23
Nov 20, 2017: Brainsway Reports Record Quarterly Revenues in Third Quarter of 2017 24
Aug 22, 2017: Brainsway Reports Continued Successful Implementation of its New Business Model in Second Quarter of 2017 25
Corporate Communications 26
Apr 03, 2017: Yaacov Michlin Leads Brainsway to its Next Growth Phase and Accelerates the Mental Health Industry 26
Jan 10, 2017: Brainsway Appoints Yaacov Michlin as CEO 27
Other Significant Developments 28
Jul 10, 2018: Sandhya Prashad, M.D., Now Offering BrainsWay Deep TMS to Patients With Depression in Houston Area 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Brainsway Ltd, Medical Equipment, Key Facts, 2017 2
Brainsway Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Brainsway Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Brainsway Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Brainsway Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Brainsway Ltd, Deals By Market, 2012 to YTD 2018 8
Brainsway Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Brainsway Raises USD8.5 Million in Financing 10
Medison Pharma Enters into Marketing and Distribution Agreement with Brainsway 11
Brainsway Enters into Distribution Agreement with Moksha8 Pharma 12
Brainsway Enters Into Co-Marketing Agreement For Deep TMS System 13
Brainsway Completes Private Placement Of Shares For US$11.8 Million 14
Brainsway Completes Public Offering Of Shares For US$6.7 Million 15
Brainsway Raises USD1 Million in Private Placement of Shares 16
Brainsway Ltd, Key Competitors 17
Brainsway Ltd, Key Employees 18
Brainsway Ltd, Subsidiaries 19

List of Figures
Brainsway Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Brainsway Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Brainsway Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Brainsway Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Brainsway Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Brainsway Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Brainsway Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Brainsway Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Brainsway Ltd (BRIN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nick Scali Ltd (NCK):企業の財務・戦略的SWOT分析
    Nick Scali Ltd (NCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • UMW Holdings Bhd (UMW):企業の財務・戦略的SWOT分析
    UMW Holdings Bhd (UMW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • PT Perusahaan Listrik Negara (Persero) Tbk:戦略・SWOT・企業財務分析
    PT Perusahaan Listrik Negara (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Perusahaan Listrik Negara (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Quidel Corp (QDEL):企業の財務・戦略的SWOT分析
    Quidel Corp (QDEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • CeoTronics AG (CEK):企業の財務・戦略的SWOT分析
    CeoTronics AG (CEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Rosneft Oil Co (ROSN):石油・ガス:M&Aディール及び事業提携情報
    Summary Rosneft Oil Company (Rosneft) is a vertically integrated oil and gas company that explores for, develops and produces crude oil, natural gas and condensates; and refines, markets and distributes petroleum products and petrochemicals. It has exploration assets across Western Siberia, Eastern …
  • Meiji Holdings Co Ltd (2269):企業の財務・戦略的SWOT分析
    Meiji Holdings Co Ltd (2269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Atlantic Pro-Nutrients Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Atlantic Pro-Nutrients Inc (APN) is a health science company that manufactures dietary supplements and functional foods. The company offers products in the areas of women's health, men's health, sports nutrition, immune health, cytokine balance support, adrenal support, antioxidants, bone he …
  • Kyocera Corporation (6971):電力:M&Aディール及び事業提携情報
    Summary Kyocera Corporation (Kyocera) is a provider of electronic equipment and components. The company’s portfolio includes semiconductor parts, ceramic components, mobile phones, electronic devices, telecommunications and information equipment, and others. These products find application in variou …
  • Society for Worldwide Interbank Financial Telecommunication:企業の戦略的SWOT分析
    Society for Worldwide Interbank Financial Telecommunication - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, k …
  • ABN AMRO Group NV (ABN):企業の財務・戦略的SWOT分析
    ABN AMRO Group NV (ABN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Kyoto University-製薬・医療分野:企業M&A・提携分析
    Summary Kyoto University (Kyoto) is a research university that offers educational services. The university provides multi disciplinary courses to students of Japan including medicine, engineering, law, letters, and science. It offers medical services, and diagnoses and treats various health problems …
  • Symetra Life Insurance Company:企業の戦略・SWOT・財務情報
    Symetra Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Symetra Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Saudi Industrial Services Co (2190):企業の財務・戦略的SWOT分析
    Summary Saudi Industrial Services Co (SISCO) is an investment holding company that develops and invests in the water, wastewater, energy, IT, sewage, and communications business. The company undertakes large scale capital investment in desalination plants, industrial estate development, free zone po …
  • Method Products, Inc.:企業の戦略的SWOT分析
    Method Products, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • JEOL Ltd. (6951):企業の財務・戦略的SWOT分析
    JEOL Ltd. (6951) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Aggreko Plc (AGK):企業の財務・戦略的SWOT分析
    Aggreko Plc (AGK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Inventec Corporation (2356):企業の財務・戦略的SWOT分析
    Inventec Corporation (2356) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Intas Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Intas Pharmaceuticals Ltd (Intas) develops, manufactures, and markets pharmaceuticals and biotechnology products for the treatment of a wide range of diseases and disorders in various therapeutic segments. The company offers products such as sevelamer, ciprofloxacin, amitryptyline, erythropo …
  • Yung Shin Pharma Ind Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Yung Shin Pharma Ind Co Ltd (Yung Shin Pharma), a subsidiary of YungShin Global Holding Corporation is a distributor of veterinary drugs, diagnostic kits and active pharmaceutical drugs. The company’s products include carlipin, glix, macgel, diabetin, domper, kascoal, biotase, bisacodyl and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆